drug
atidarsagene autotemcel
Marketedupdated 6mo agoby Orchard Therapeutics Ltd (Inactive)
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
News(1)
- Ultragenyx wins FDA greenlight for first Sanfilippo therapy, priced at nearly $4MThe market approval for Fayuvi, which was rejected in 2025 due to manufacturing problems, comes shortly after Ultragenyx got the FDA nod for its first gene therapy last month.biospace · 1mo ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that